)
)
Glycorex Transplantation Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation AB is a Swedish biotechnology company headquartered in Uppsala. It owns GlycoMab, a patented technology used to create antibodies that are immunosuppressive drugs like Atgam, which the company produces. The company also collaborates with third-party companies for the development and commercialization of other therapies.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
GTAB
Country
🇸🇪 Sweden